Swedish Orphan Biovitrum Operating Expenses 2019-2024 | BIOVF
Swedish Orphan Biovitrum operating expenses for the twelve months ending June 30, 2024 were $1.847B, a 25.62% increase year-over-year.
- Swedish Orphan Biovitrum annual operating expenses for 2023 were $1.703B, a 14.72% increase from 2022.
- Swedish Orphan Biovitrum annual operating expenses for 2022 were $1.484B, a 7.92% increase from 2021.
- Swedish Orphan Biovitrum annual operating expenses for 2021 were $1.375B, a 20.83% increase from 2020.